Cannara Biotech Inc.
LOVE.V
TSX
| 08/31/2025 | 05/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.93% | 4.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.21% | 4.90% | |||
| Cost of Revenue | 14.40% | 0.53% | |||
| Gross Profit | -0.90% | 10.30% | |||
| SG&A Expenses | 13.46% | 3.49% | |||
| Depreciation & Amortization | 257.28% | -19.36% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.74% | 1.10% | |||
| Operating Income | -22.06% | 18.57% | |||
| Income Before Tax | -19.64% | 24.66% | |||
| Income Tax Expenses | -23.76% | 18.72% | |||
| Earnings from Continuing Operations | -18.00% | 27.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.00% | 27.20% | |||
| EBIT | -22.06% | 18.57% | |||
| EBITDA | -5.78% | 9.87% | |||
| EPS Basic | -18.01% | 25.78% | |||
| Normalized Basic EPS | -29.08% | 23.14% | |||
| EPS Diluted | -22.89% | 10.94% | |||
| Normalized Diluted EPS | -29.86% | 23.56% | |||
| Average Basic Shares Outstanding | 0.01% | 0.96% | |||
| Average Diluted Shares Outstanding | 0.83% | 0.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||